Spitz R - Search Results

1

Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.

Spitz R, Oberthuer A, Zapatka M, Brors B, Hero B, Ernestus K, Oestreich J, Fischer M, Simon T, Berthold F. Spitz R, et al. Genes Chromosomes Cancer. 2006 Dec;45(12):1130-42. doi: 10.1002/gcc.20376. Genes Chromosomes Cancer. 2006. PMID: 16958102

2

Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.

Spitz R, Hero B, Westermann F, Ernestus K, Schwab M, Berthold F. Spitz R, et al. Genes Chromosomes Cancer. 2002 Jul;34(3):299-305. doi: 10.1002/gcc.10070. Genes Chromosomes Cancer. 2002. PMID: 12007190

3

Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F. Spitz R, et al. Clin Cancer Res. 2003 Jan;9(1):52-8. Clin Cancer Res. 2003. PMID: 12538451

4

FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F. Spitz R, et al. Med Pediatr Oncol. 2003 Jul;41(1):30-5. doi: 10.1002/mpo.10313. Med Pediatr Oncol. 2003. PMID: 12764740

5

Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F. Spitz R, et al. Clin Cancer Res. 2003 Oct 15;9(13):4835-40. Clin Cancer Res. 2003. PMID: 14581355

6

Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.

Spitz R, Betts DR, Simon T, Boensch M, Oestreich J, Niggli FK, Ernestus K, Berthold F, Hero B. Spitz R, et al. Cancer Genet Cytogenet. 2006 May;167(1):51-6. doi: 10.1016/j.cancergencyto.2005.09.001. Cancer Genet Cytogenet. 2006. PMID: 16682287

7

Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.

Spitz R, Hero B, Simon T, Berthold F. Spitz R, et al. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3368-73. doi: 10.1158/1078-0432.CCR-05-2495. Clin Cancer Res. 2006. PMID: 16740759

8

Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma.

Theissen J, Oberthuer A, Hombach A, Volland R, Hertwig F, Fischer M, Spitz R, Zapatka M, Brors B, Ortmann M, Simon T, Hero B, Berthold F. Theissen J, et al. Among authors: spitz r. Genes Chromosomes Cancer. 2014 Aug;53(8):639-49. doi: 10.1002/gcc.22174. Epub 2014 Apr 15. Genes Chromosomes Cancer. 2014. PMID: 24737690

9

Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q.

Boensch M, Oberthuer A, Fischer M, Skowron M, Oestreich J, Berthold F, Spitz R. Boensch M, et al. Among authors: spitz r. Diagn Mol Pathol. 2005 Sep;14(3):177-82. doi: 10.1097/01.pas.0000176767.10800.17. Diagn Mol Pathol. 2005. PMID: 16106200

10

MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.

Spitz R, Hero B, Skowron M, Ernestus K, Berthold F. Spitz R, et al. Eur J Cancer. 2004 Dec;40(18):2753-9. doi: 10.1016/j.ejca.2004.05.002. Eur J Cancer. 2004. PMID: 15571958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters